Addressing the operational challenges of making autologous cell therapies remains a major challenge for industry.

With an increasingly promising roster of approved cell therapies still burdened by complex manufacturing, multiple companies have emerged in recent years on a mission to simplify production for the ...

It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the US approval of three cell therapy products: Iovance ...

Pascal Touchon serves as global strategy advisor to RoslinCT and board director, bringing over four decades of international experience in the biopharmaceutical industry, combining operational ...

Ori Biotech has lassoed a significant milestone for its space- and cost-efficient cell and gene therapy manufacturing platform. The FDA has granted the company’s IRO platform an Advanced Manufacturing ...

TOKYO and LOS ANGELES, Aug. 05, 2026 (GLOBE NEWSWIRE) -- CellFiber Co., Ltd. (“CellFiber”), a Tokyo-based biotechnology company built on its proprietary CellFiber® cell encapsulation platform, and ...

Relation Therapeutics has unveiled MORGAN, an AI “foundation model of the cell” meant to predict how human cells respond to drugs and genetic changes. On the same day, it expanded a collaboration with ...

The AMT designation gives Cellares’ clients using the Cell Shuttle priority review with the FDA leading to accelerated regulatory filings SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the ...

Viral safety is a nonnegotiable regulatory expectation for biologic drug substances manufactured using mammalian cell culture ...